Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

87.07
+4.525.47%
Post-market: 87.070.00000.00%19:37 EDT
Volume:555.28K
Turnover:47.42M
Market Cap:2.58B
PE:-23.92
High:87.17
Open:83.71
Low:80.76
Close:82.55
52wk High:170.87
52wk Low:32.21
Shares:29.68M
Float Shares:19.02M
Volume Ratio:1.19
T/O Rate:2.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6399
EPS(LYR):-0.7339
ROE:-40.80%
ROA:-7.89%
PB:10.58
PE(LYR):-118.63

Loading ...

If You Believe In Transformative AI Healthcare Then These Three Stocks Could Define Your Next Cycle

Simply Wall St.
·
Apr 27

Piper Sandler Reaffirms Their Buy Rating on GeneDx Holdings (WGS)

TIPRANKS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), GeneDx Holdings (WGS) and Agios Pharma (AGIO)

TIPRANKS
·
Apr 21

GeneDx Holdings Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Apr 21

GeneDx price target raised to $100 from $70 at Canaccord

TIPRANKS
·
Apr 20

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

GlobeNewswire
·
Apr 16

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

GeneDx to report first-quarter results after market close, host conference call

Reuters
·
Apr 14

MGI Tech Celebrates 10 Years of Innovation, Empowering 3,560 Users Across Six Continents

prnewswire
·
Apr 13

Cathie Wood Buys the Dip in GeneDx (WGS): 142% Upside Ahead

TIPRANKS
·
Apr 10

Assessing GeneDx Holdings (WGS) Valuation After Technical Weakness And Mixed Investor Sentiment

Simply Wall St.
·
Apr 05

GeneDx Holdings Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 30

GeneDx price target lowered to $100 from $170 at Guggenheim

TIPRANKS
·
Mar 30

A Look At GeneDx Holdings (WGS) Valuation After Ark Buying And Zevra Genetic Testing Partnership

Simply Wall St.
·
Mar 19

Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note?

Benzinga_recent_news
·
Mar 12

Analysts’ Top Healthcare Picks: GeneDx Holdings (WGS), Zymeworks (ZYME)

TIPRANKS
·
Mar 12

GeneDx SAVES-Kids study reports USD 80,000 average healthcare cost savings per child after exome and genome testing

Reuters
·
Mar 12

GeneDx to Launch Genetic Testing Program With Zevra Therapeutics to Support Patients With Suspected Niemann-Pick Disease Type C

THOMSON REUTERS
·
Mar 10

Major Insider Moves at GeneDx Holdings Shake Up Investor Buzz

TIPRANKS
·
Mar 06

Director and 10% Owner Keith A. Meister Acquires GeneDx Holdings Common Shares

Reuters
·
Mar 06